Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion type Assertion NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_head.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion evidence source_evidence_literature NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion SIO_000772 17405907 NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion wasDerivedFrom befree-2016 NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.
- NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_assertion wasGeneratedBy ECO_0000203 NP602484.RAta4GFR76K5WVPc54eSr4Ml6f8MiEo-cilI9j3gLJd80130_provenance.